FDA Approves Herzuma for Breast Cancer

The FDA approved Herzuma, a HER2/neu receptor antagonist biosimilar to Herceptin for breast cancer treatment.

DECEMBER 17, 2018

FDA Approves Ajovy for Migraine Prevention

The FDA approved Ajovy, a humanized monoclonal antibody, for the prevention of migraine in adults. 

SEPTEMBER 18, 2018

Teva Gains Approval to Market Generic EpiPen

The FDA approved the first generic version of Mylan’s EpiPen and EpiPen Jr (epinephrine) auto-injector for ...

AUGUST 16, 2018

New Abuse-Deterrent Opioid One Step Closer to Approval

An FDA committee recommended approval of Vantrela ER, a hydrocodone ER tablet with abuse-deterrent capabilities.

JUNE 8, 2016

FDA Approves Cinqair To Treat Severe Asthma

The new biologic is indicated for add-on maintenance treatment of adults with severe asthma with an eosinophilic ...

MARCH 24, 2016